Wang G, Meyer JG, Cai W, Softic S, Li ME, Verdin E, et al
This triple-agonist compound, which is known for its action on GLP-1, GIP, and glucagon receptors, has become a key focus in metabolic and weight management studies
Therefore, the possibility that depression disorders could be effectively influenced by a primary antiulcer agent with a cyto/organoprotective activity, such as the novel stomach pentadecapeptide bpc 157, was investigated in two rat depression assays
Administer the injection intramuscularly as directed by your healthcare provider
PubChem Compound Summary for CID 9941957
Retatrutide is a metabolic fat-loss compound